Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.

Sternberg, C.N.; Mulder, P.H.M. de; Schornagel, J.H.; Theodore, C.; Fossa, S.D.; Oosterom, A.T. van; Witjes, J.A.; Spina, M.; Groeningen, C.J. van; Duclos, B.; Roberts, J.T.; Balincourt, C. de; Collette, L.

Fulltext:

49305.pdf

Embargo:

until further notice

Size:

134.9Kb

Format:

PDF

Description:

publisher's version

Publication year

2006

Author(s)

Source

European Journal of Cancer, 42, 1, (2006), pp. 50-54

ISSN

0959-8049

DOI

https://doi.org/10.1016/j.ejca.2005.08.032

Publication type

Article / Letter to editor

Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/49305

Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.

Radboud Repository

Radboud Repository

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.

Publication year

Author(s)

Source

ISSN

DOI

Publication type

Organization

Former Organization

Journal title

Volume

Issue

Page start

Page end

Subject

This item appears in the following Collection(s)